Skip to Content
Merck
  • APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.

APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.

Nature immunology (2001-03-23)
G Yu, T Boone, J Delaney, N Hawkins, M Kelley, M Ramakrishnan, S McCabe, W R Qiu, M Kornuc, X Z Xia, J Guo, M Stolina, W J Boyle, I Sarosi, H Hsu, G Senaldi, L E Theill
ABSTRACT

We report that the tumor neurosis factor homolog APRIL (a proliferation-inducing ligand) stimulates in vitro proliferation of primary B and T cells and increases spleen weight due to accumulation of B cells in vivo. APRIL functions via binding to BCMA (B cell maturation antigen) and TACI (transmembrane activator and CAML-interactor) and competes with TALL-I (also called BLyS or BAFF) for receptor binding. Soluble BCMA and TACI specifically prevent binding of APRIL and block APRIL-stimulated proliferation of primary B cells. BCMA-Fc also inhibits production of antibodies against keyhole limpet hemocyanin and Pneumovax in mice, indicating that APRIL and/or TALL-I signaling via BCMA and/or TACI are required for generation of humoral immunity. Thus, APRIL-TALL-I and BCMA-TACI form a two ligands-two receptors pathway involved in stimulation of B and T cell function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
APRIL human, recombinant, expressed in Hi-5 Insect cells, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture
Sigma-Aldrich
APRIL from mouse, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture
Sigma-Aldrich
BCMA human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture